The dentate gyrus (DG), as a part of the hippocampal formation, is considered one of the brain areas involved in pain perception. This area contains opioid and orexin receptors. The present study examined the hypothesis that the interaction between opioidergic and orexinergic receptors in the DG area may influence acute pain-related behaviors. Two hundred thirty-nine adult male Wistar rats received unilateral microinjections of different doses of morphine (5, 10, 25, and 50 mM/0.5µl saline) and orexin A (0.25, 0.5, 1, and 2 nM/0.5µl saline) to assess their effects as opioid and orexin receptor agonists in the DG. Following this, the rats were administered varying doses of SB334867 (3, 10, 30, and 100 nM /0.5μL DMSO), an orexin-1 receptor (OX1r) antagonist, or TCS OX2 29, (3, 10 and 30 nM/0.5μL DMSO), an orexin-2 receptor (OX2r) antagonist before an effective dose of orexin A (1 nM /0.5μL saline). They also received naloxone (1.5, 5, 15, and 45 mM/0.5μL saline) before the same effective dose of orexin A. Finally, rats received varying doses of SB334867 (10, 30, and 100 nM /0.5μL DMSO) or TCS OX2 29 (1, 3, 10, and 30 nM /0.5μL DMSO) before an effective dose of morphine (25 mM/0.5μL saline). The tail-flick test was employed to evaluate their acute pain thresholds. The findings demonstrated that the administration of morphine and orexin A within the DG resulted in antinociceptive responses. However, SB334867 and TCS OX2 29 significantly diminished the antinociceptive responses of morphine and orexin A. Naloxone also reduced the analgesic effects of orexin A. These findings suggest a role for opioidergic and orexinergic systems in the DG in modulating acute pain. A better understanding of the neural circuits regulating pain will advance the search for novel treatments.